🔎 Trials Near Me

Beranda › Kanker Paru Sel Kecil › California › Los Angeles

Uji klinis Kanker Paru Sel Kecil di Los Angeles, CA

20 studi untuk Kanker Paru Sel Kecil mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1
  • University of California - Los Angeles, Los Angeles
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06586957

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

Menerima pesertaFase 3
  • GSK Investigational Site, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07099898

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Menerima pesertaFase 1/2
  • University of Southern California, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Menerima pesertaFase 1/2
  • START Los Angeles, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07488676

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Menerima pesertaFase 2
  • Valkyrie Clinical Trials, Inc., Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07459634

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Menerima pesertaFase 3
  • Valkyrie Clinical Trials, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07625644

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Menerima pesertaFase 1/2
  • Avenzo Therapeutics Recruiting Site, Los Angeles
  • Avenzo Therapeutics Recruiting Site, Los Angeles
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07038343

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of California LA, Los Angeles
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06726148

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Menerima pesertaFase 1/2
  • Cedars Sinai Medical Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06892548

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Menerima pesertaFase 1
  • University of Southern California, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06922539

A Study of MGC026 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • The Angeles Clinic and Research Institute, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Menerima pesertaFase 3
  • UCLA Hematology-Oncology, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06203210

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Menerima pesertaFase 2
  • Valkyrie Clinical Trials, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05882058

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Menerima pesertaFase 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT05652686

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Menerima pesertaFase 1
  • University of Southern California, Norris Comprehensive Cancer Center, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT06598306

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Menerima pesertaFase 1
  • Start Lacn, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT07517198

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Menerima peserta
  • Oncology Institute for Hope and Innovation, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Research Site 125, Los Angeles
  • Research Site 133, Los Angeles
  • Research Site 103, Los Angeles
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT05914116

Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

Menerima pesertaFase 2
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Semua usia · Semua jenis kelamin · Diperbarui 17 Nov 2025 · NCT05588388

Uji klinis Kanker Paru Sel Kecil di kota lain

Studi lain di Los Angeles

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.